You are here:
tadalafil (Cialis)
Advice
In the absence of a submission from the holder of the marketing authorisation: tadalafil (Cialis) is not recommended for use within NHS Scotland.
Indication under review: Treatment of the signs and symptoms of benign prostatic hyperplasia in adult males.
The holder of the marketing authorisation has not made a submission to SMC regarding this product in this indication. As a result we cannot recommend its use within NHSScotland.
Drug Details
| Drug Name: | tadalafil (Cialis) |
|---|---|
| SMC Drug ID: | 849/12 |
| Manufacturer: | Eli Lilly and Company Ltd |
| Indication: | Treatment of the signs and symptoms of benign prostatic hyperplasia in adult males. |
| BNF Category: | |
| Sub Category: | 7.4 Drugs for genito-urinary disorders |
| Submission Type: | Non submission |
| Status: | Not Recommended |
| Date Advice Published: | 14 January 2013 |